SCHEMBL19308

SCHEMBL19308

O=C(O)[C@]1(O)CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2183127 1.00
SCHEMBL313044 1.00
Water SCHEMBL28255872 0.98 ARG1 (0.37)
Hydrochloric Acid SCHEMBL7981515 0.98 ARG1 (0.37)
Hydrochloric Acid SCHEMBL3662817 0.98 ARG1 (0.37)
Iodide SCHEMBL28627113 0.95 ARG1 (0.36)
SCHEMBL562022 0.93 ARG1 (0.33)
Hydrochloric Acid SCHEMBL17674506 0.91 ARG1 (0.33)
Ethylenediamine SCHEMBL27480765 0.89 ARG1 (0.37)
SCHEMBL17578914 0.82 HTR2A (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4266 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122071428-A Preparation method of Epimer Fu Kasai and intermediate thereof 扬子江药业集团南京海陵药业有限公司 2026-05-22 CN claimed
EP-4731638-A1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS BicycleTx Limited (GB) 2026-04-29 EP claimed
US-12606594-B2 Heterotandem bicyclic peptide complexes BICYCLETX LIMITED (GB) 2026-04-21 US claimed
US-20250340595-A1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1) BICYCLETX LTD (GB) 2025-11-06 US claimed
US-12435107-B2 Heterotandem bicyclic peptide complex BICYCLETX LIMITED (GB) 2025-10-07 US claimed
WO-2025124444-A1 USE OF HYDROXYPROLINE AND DERIVATIVE THEREOF, BIOLOGICAL HERBICIDE, BROAD-SPECTRUM HERBICIDE, AND WEED CONTROL METHOD 三亚市国家耐盐碱水稻技术创新中心 2025-06-19 WO claimed
CN-120142669-A Serum protein and metabolic marker for diagnosis or auxiliary diagnosis of colorectal cancer or ulcerative colitis and application thereof 上海中医药大学附属龙华医院 2025-06-13 CN claimed
CN-120130489-A Application of hydroxyproline and derivatives thereof, biological herbicide, broad-spectrum herbicide and weed control method 三亚市国家耐盐碱水稻技术创新中心 2025-06-13 CN claimed
US-20250186539-A2 METHODS FOR TREATING CANCER BICYCLETX LIMITED (GB) 2025-06-12 US claimed
EP-3536780-B1 PROLINE HYDROXYLASE AND APPLICATION THEREOF ASYMCHEM LAB TIANJIN CO LTD (CN) 2025-05-14 EP claimed
EP-0109047-B1 TOTAL SYNTHESIS OF ANTITUMOR ANTIBIOTICS Bristol-Myers Company (US) 1987-11-04 EP claimed
WO-1987004925-A1 STIMULATION OF ANGIOGENESIS BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) 1987-08-27 WO claimed
US-4625016-A 4-HYDROXYPROLINE POLYESTERS AND POLYPEPTIDES UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 1986-11-25 US claimed
EP-0078191-B1 COLLAGEN INHIBITING COMPOSITIONS AND PROCESSES FOR MANUFACTURING AND USING THE SAME UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 1986-09-03 EP claimed
US-4482725-A ANGIOTENSIN CONVERTING ENZYME INHIBITOR E. R. SQUIBB & SONS, INC. (US) 1984-11-13 US claimed
EP-0109047-A1 Total synthesis of antitumor antibiotics Bristol-Myers Company (US) 1984-05-23 EP claimed
US-4428939-A POLYMERIC HYDROXYPROLINE FOR REDUCTION OF SCAR TISSUE COLLEGE OF MEDICINE AND DENTISTRY OF NEW JERSEY 1984-01-31 US claimed
US-4427587-A COUPLING ALKYL ESTER OF 4-HYDROXY PROLINE WITH NITRO, OXY, AROMATIC ACID, REDUCING NITRO GROUP AND CYCLIZATION BRISTOL-MYERS COMPANY (US) 1984-01-24 US claimed
EP-0078191-A2 Collagen inhibiting compositions and processes for manufacturing and using the same UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 1983-05-04 EP claimed
US-4155762-A ALKALI OR ALKALINE EARTH METAL SALT OF AMINO CARBOXYLIC OR SULFONIC ACID RICOH CO., LTD. (JP) 1979-05-22 US claimed